WHO ICTRP trial
AMJ-504 Japan Trial
JPRN-jRCT2072210125 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2072210125 |
|---|---|
| Public title | AMJ-504 Japan Trial |
| Scientific title | AMJ-504 Japan Trial |
| Primary sponsor | Junya Ako |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Tricuspid valve regurgitation Tricuspid valve regurgitation;D014262;Tricuspid valve regurgitation |
| Interventions | The treatment of patients with symptomatic, severe tricuspid valve regurgitation, whose symptoms and TR severity persist despite being optimally treated with medical therapy.;TTVR |
| Registration date | Nov 2, 2022 |
| Target size | 35 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: